Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
The Lancet. Infectious Diseases|April 17, 2015
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study, Dianne Carey, Rebekah Puls, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus-Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings From the Expanded PrEP Implementation in Communities-New South Wales Prospective Implementation StudyJanaki Amin, Stefanie Vaccher, David J Templeton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2021
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyHeather Valerio, Maryam Alavi, Matthew Law, et al.
The Lancet. HIV|October 2, 2015
Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysisMark A Boyd, Cecilia L Moore, Jean-Michel Molina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosisDavid A Brown, Carsten Stephan, Robyn L Ward, et al.
Tuberculosis (Edinburgh, Scotland)|May 1, 2012
A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assaysDenise C Hsu, John J Zaunders, Marshall Plit, et al.
JAMA Network Open|December 23, 2020
Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With MenHamish McManus, Andrew E Grulich, Janaki Amin, et al.
Drug and Alcohol Dependence|May 5, 2015
The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort studyClaire M Vajdic, Sadaf Marashi Pour, Sadaf Marashi Pour, et al.
Plos One|February 28, 2015
Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infectionJanaki Amin, Mark A Boyd, Nagalingeswaran Kumarasamy, et al.
AIDS (London, England)|June 8, 2021
Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, AustraliaFengyi Jin, Janaki Amin, Rebecca Guy, et al.
Pageof 20